JAYNEL RHUDD: Open Payments
NPI 1619341096 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 17 payments from 8 companies in 2025. Trend: 2023 $324 · 2024 $612 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $331 |
| Axsome Therapeutics, Inc. | 3 | $156 |
| Gilead Sciences, Inc. | 1 | $123 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $76 |
| Neurelis, Inc. | 1 | $35 |
| UCB, Inc. | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $14 |
Products named: QULIPTA, Symbravo, JARDIANCE, VALTOCO, Fintepla, ULTOMIRIS, BOTOX, ZAVZPRET.
Industry payments across DE — which companies pay providers there.
